Biological E's Corbevax gets emergency approval for 12-18 age group

COVID-19 vaccine Corbevax gets EUA for the 12 to 18 years age group

We are even more closer to finishing our global fight against pandemic, says company

Biological E’s vaccine Corbevax gets emergency use authorisation for 12-18 age group

CoronavirusThe Drugs Controller General of India (DCGI) had already approved Corbevax for restricted use in emergency situation among adults on December 28, 2019.TNM Staffpti / Representational imageBiological E. Limited (BE), on Monday, February 21 announced that its Corbevax vaccine has received emergency use authorisation (EUA) from India's drug regulator for the 12 to 18-year age group. The Drugs Controller General of India (DCGI) had alread…

SII seeks emergency use approval for Covovax Covid vaccine for 12-17 age group

The government has not yet decided on vaccinating those aged below 15 against Covid. India has been using Bharat Biotech's Covaxin to vaccinate adolescents between 15 and 18 years.

Biological E's Corbevax gets emergency approval for 12-18 age group

Hyderabad-based pharmaceutical company Biological E Ltd on Monday said its coronavirus vaccine, Corbevax, also India's third homegrown vaccine, has received an emergency use approval in India for use in children aged 12 to 18 years.  India has so far only started vaccinating children aged 15 and above. According to government figures, more than 76 million children between 15 and 17 have been inoculated, mainly using Covaxin.

Biological E's Covid-19 Vaccine Corbevax Gets Emergency Use Approval for Children Aged 12-18

The approval comes at a time when schools across the country are opening up as Covid cases are witnessing a considerable decline.

COVID-19: Biological E's Corbevax vaccine gets DCGI nod for use on children between 12 and 18 years of age

Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) Protein sub-unit vaccine against COVID-19.